Your AI-Trained Oncology Knowledge Connection!

Gastrointestinal Cancer

Latest News

Radiotherapy Plus Sintilimab and Chemo Improves pCR in Rectal Cancer

July 20th 2025

Short-course radiotherapy combined with sintilimab plus oxaliplatin-capecitabine yielded a pCR rate of 59.2% vs 32.7% with the control arm in locally advanced rectal cancer.

Perioperative Chemo Improves Survival, Control in Esophageal Cancer

By Tim Cortese

July 19th 2025

Transarterial chemoembolization plus sorafenib did not significantly improve overall survival in advanced hepatocellular carcinoma vs sorafenib alone.

Transarterial Chemoembolization Regimen Shows PFS Improvement in HCC

By Roman Fabbricatore

July 16th 2025

Phase 1b data show antitumor activity with the givastomig combination across a wide range of CLDN18.2 expression.

Givastomig Regimen Yields Preliminary Activity in Gastric/GEJ Cancers

By Kristi Rosa

July 14th 2025

Data from the phase 3 BEACON CRC trial support the approval of encorafenib plus cetuximab for this colorectal cancer population in China.

Encorafenib Combo Earns Chinese Approval in BRAF V600E+ Metastatic CRC

By Russ Conroy

July 13th 2025

Latest CME Events & Activities

Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing

GI Tumor Board—Applying Recent Advances in Biomarker Testing and Treatment in Metastatic Colorectal Cancer

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

Oncology Town Hall™ 2025 ESMO-GI Congress Highlights: The Latest Data on Immune-Based Strategies Across Hepato...

July 15, 2025

Community Practice Connections™: 14th Asia-Pacific Primary Liver Cancer Expert Meeting

PER® Liver Cancer Tumor Board: How Do Evolving Data for Immune-Based Strategies in Resectable and Unresectable HCC Impact Multidisciplinary Patient Management Today… and Tomorrow?